Sherbrooke Park Advisers LLC Maravai Lifesciences Holdings, Inc. Transaction History

Sherbrooke Park Advisers LLC

  • $436 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$4.7 - $9.87 $112,687 - $236,643
23,976 Added 168.01%
38,247 $251 Million
Q3 2023

Nov 14, 2023
BUY
$9.14 - $12.85 $130,436 - $183,382
14,271 New
14,271 $143 Million
Q4 2022

Feb 14, 2023
BUY
$12.5 - $24.78 $211,250 - $418,782
16,900 New
16,900 $242 Million

Others Institutions Holding MRVI

# of Institutions
234
Shares Held
140M
Call Options Held
223K
Put Options Held
19.4K
View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI Quotes by TradingView
  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email